Can the HPV vaccine protect transplant patients?
NCT ID NCT05557370
First seen May 02, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study looks at how well the HPV9 vaccine (Gardasil 9) works in people who have had a kidney or other solid organ transplant. Researchers will measure antibody levels in 30 participants over 24 months and compare them to healthy individuals. The goal is to see if the vaccine provides strong protection for this vulnerable group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Froedtert Lutheran Memorial Hospital
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.